CANTON, Mass., January 13, 2005 –Avitar, Inc. (Amex: AVR - News), the company that developed the world’s first on-site oral test for drugs-of-abuse, today announced the availability of the Drug-Free Workplace Profile; a self-audit risk assessment tool that helps corporations review and gain better insight into the issues and problems associated with developing and implementing a drug-free workplace policy.
"Ten percent of the U.S. workforce abuse drugs adversely impacting employers by more than $110B every year," shares Peter Phildius, Chairman and CEO of Avitar. "Cost and safety issues associated with the lack of a successful corporate drug testing program include: higher employee turnover / absenteeism, workplace violence, increased on-the-job accidents, elevated employee theft / inventory shrinkage, as well as higher workers compensation rates and healthcare benefit utilization. This assessment tool will help employers identify key issues to be considered in developing a drug-free workplace policy and ultimately provide a safer and more competitive work environment."
Avitar was a contributing author to Laurdan Associates, developer of 2005 Drug Free Workplace Profile, and the Employment-Labor Law Audit (ELLA), the nation’s leading HR auditing and employment practices risk assessment tool.
The Drug-Free Workplace self audit questionnaire will be available in print form in February, or interactively via the Internet, in March of this year, at a price of $100 per user.
Avitar, Inc. develops, manufactures and markets innovative and proprietary products for the oral fluid diagnostic market as well as medical grade polyurethane foam. Oral fluid diagnostics includes the estimated $1.5 billion drugs-of-abuse testing market. Avitar's products include ORALscreen® the world's first non-invasive, rapid, on-site oral fluid test for drugs-of-abuse. Additionally, Avitar manufactures and markets HYDRASORB® an absorbent topical dressing for the wound care. For more information, see Avitar's website at https://avitarinc.com.
Safe Harbor Statement. This release contains forward looking statements that are subject to risks and uncertainties including the development and marketing of new applications and other risks that are detailed from time to time in the Company's filings with the Securities and Exchange Commission. In view of such risks and uncertainties, the Company's actual results could differ materially from those anticipated in such forward looking statements.
